Complement Factor 1 Inhibitor Improves Cardiopulmonary Function in Neonatal Cardiopulmonary Bypass

Annals of Thoracic Surgery

Volumn 83, Issue 4, 2007, Pages 1477-1483

  Baig, Kamran ^a   Nassar, Rashid ^b   Craig, Damian M ^b   Quick Jr , George ^b   Jiang, Hai Xiang ^b   Frank, Michael M ^b   Lodge, Andrew J ^b   Anderson, Page A W ^b   Jaggers, James ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERINERT; COMPLEMENT COMPONENT C1S INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOPULMONARY FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; HEART DISEASE; HEART LEFT VENTRICLE PRESSURE; LUNG ALVEOLUS OXYGEN TENSION; LUNG COMPLIANCE; LUNG DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; WEIGHT GAIN;

ANIMALS; ANIMALS, NEWBORN; CARDIOPULMONARY BYPASS; COMPLEMENT C1 INHIBITOR PROTEIN; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HEART FUNCTION TESTS; HEART RATE; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; PREOPERATIVE CARE; RANDOM ALLOCATION; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SWINE;

EID: 33947321937     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.10.049     Document Type: Article

References (22)

1. Kirklin J.K., Westaby S.S., Blackstone E.H., Kirklin J.W., Chenoowith D.E., and Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86 (1983) 845-857
2. Seghaye M.C., Duchateau J., Grabitz R.G., et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to post-operative multiple system organ failure. J Thorac Cardiovasc Surg 106 (1993) 978-987
3. Stiller B., Sonntag J., Dahnert I., et al. Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor. Intens Care Med 27 (2001) 193-200
4. Little W.C., Cheng C.P., Mumma M., Igarashi Y., Vinten-Johansen J., and Johnston W.E. Comparisons of LV contractile performance derived from pressure volume loops in conscious dogs. Circulation 80; (1989) 1378-1387
5. Glower D.D., Spratt J.A., Snow N.D., et al. Linearity of Frank-Starling relationship in the intact heart: the concept of pre-load recruitable stroke work. Circulation 71 (1985) 994-1009
6. Fredericjson J.W., Weiss J.L., and Weisfeldt M.L. Time constant of isovolumic pressure fall: determinants in the working left ventricle. Am J Physiol 235 (1978) H701-H706
7. Yellin E.L., Hori M., Yoran C., Sonnenblick E.H., Gabbay A.E., and Frater R.W. Left ventricular relaxation in the filling and nonfilling intact canine heart. Am J Physiol 250 (1986) H620-H629
8. Pinheiro J., and Bates D.M. Mixed-effects models in S and S-Plus (2000), Springer-Verlag, New York
9. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2005. Available at: http://www.R-project.org.
10. Georgakopoulos D., and Kass D.A. Minimal force-frequency modulation of inotropy and relaxation of in-situ murine heart. J Physiol 534 (2001) 534-545
11. Meri S., Aronen M., and Leijala M. Complement activation during cardiopulmonary bypass in children. Complement 5 (1988) 46-54
12. Schapira M., Scott C.F., and Coleman R.W. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 69 (1982) 462-468
13. Pixley R.A., Schapira M., and Coleman R.W. The regulation of human FXIIa by plasma proteinase inhibitors. J Biol Chem 260 (1985) 1723-1729
14. Klima U., Kutschka I., Warnecke G., et al. Improved right ventricular function after intracoronary administration of C1 esterase inhibitor in a right heart transplant model. Eur J Cardiothorac Surg 18 (2000) 321-327
15. Horstick G., Heimann A., Gotze O., et al. Intra-coronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia reperfusion. Circulation 95 (1997) 701-708
16. Akita N., Nakase H., Kaido T., Kanemoto Y., and Sakaki T. Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 52 (2003) 395-401
17. Scherer M., Demertzis S., Langer F., Moritz A., and Schafers H.J. C1 esterase inhibitor reduces the reperfusion injury after lung transplantation. Ann Thorac Surg 73 (2002) 233-239
18. Nurnberger W., Heying R., Burdach S., and Gobel U. C1 Esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 75 (1997) 95-101
19. Bauernschmitt R., Bohrer H., and Hagl S. Rescue therapy with C1 esterase inhibitor concentrate after emergency coronary surgery for failed PTCA. Intens Care Med 24 (1998) 635-638
20. Wachtfogel Y.T., Harpel P.C., Edmunds Jr. L.H., and Coleman R.W. Formation of C1s-C1 inhibitor, kallikrein-C1 inhibitor, and plasmin alpha 2-plasmin inhibitor complexes during cardiopulmonary bypass. Blood 73 (1989) 468-471
21. Tassani P., Kunkel R., Richter J.A., et al. Effect of C1-esterase inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates. J Cardiothorac Vasc Anesth 15 (2001) 469-473
22. Chai P., Nassar R., Oakeley A.E., et al. Soluble complement receptor-1 protects heart, lung and cardiac myofilament function from cardiopulmonary bypass damage. Circulation 101 (2000) 541-546